+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CDMO"

CRDMO Market - Global Outlook & Forecast 2024-2029 - Product Thumbnail Image

CRDMO Market - Global Outlook & Forecast 2024-2029

  • Report
  • February 2025
  • 302 Pages
  • Global
From
From
From
From
Biologics Outsourcing Market - Global Forecast 2025-2032 - Product Thumbnail Image

Biologics Outsourcing Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
From
From
From
Fill Finish Manufacturing Market - Global Forecast 2025-2032 - Product Thumbnail Image

Fill Finish Manufacturing Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 183 Pages
  • Global
From
Unit Dose Manufacturing Market - Global Forecast 2025-2032 - Product Thumbnail Image

Unit Dose Manufacturing Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 189 Pages
  • Global
From
From
From
From
From
From
From
From
Antibody Drug CDMO Service Market - Global Forecast 2025-2030 - Product Thumbnail Image

Antibody Drug CDMO Service Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Loading Indicator

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing. CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs). Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more